You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Pfizer signs deal to allow expanded use of COVID-19 treatment

Pfizer has signed a new deal with UN-backed organisation the Medicines Patent Pool (MPP) to increase access to its COVID-19 treatment for low- and middle-income countries.